SEI Investments’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-18,606
| Closed | -$1.58M | – | 2580 |
|
|
2020
Q3 | $1.58M | Sell |
18,606
-134,531
| -88% | -$6.8M | ﹤0.01% | 1392 |
|
|
2020
Q2 | $5.43M | Buy |
153,137
+101,959
| +199% | +$2.98M | 0.02% | 822 |
|
|
2020
Q1 | $688K | Buy |
51,178
+4,584
| +10% | +$77.1K | ﹤0.01% | 1624 |
|
|
2019
Q4 | $988K | Sell |
46,594
-33,725
| -42% | -$595K | ﹤0.01% | 1640 |
|
|
2019
Q3 | $1.06M | Buy |
80,319
+2,339
| +3% | +$34.4K | ﹤0.01% | 1580 |
|
|
2019
Q2 | $1.08M | Buy |
77,980
+3,818
| +5% | +$57.5K | ﹤0.01% | 1575 |
|
|
2019
Q1 | $1.42M | Buy |
74,162
+65,722
| +779% | +$1.06M | ﹤0.01% | 1453 |
|
|
2018
Q4 | $175K | Sell |
8,440
-1,134
| -12% | -$22.5K | ﹤0.01% | 2067 |
|
|
2018
Q3 | $202K | Sell |
9,574
-46,977
| -83% | -$1.11M | ﹤0.01% | 1924 |
|
|
2018
Q2 | $1.34M | Buy |
56,551
+52,172
| +1,191% | +$1.05M | ﹤0.01% | 1480 |
|
|
2018
Q1 | $64K | Buy |
4,379
+1,589
| +57% | +$26K | ﹤0.01% | 2285 |
|
|
2017
Q4 | $45K | Sell |
2,790
-528
| -16% | -$6.23K | ﹤0.01% | 2392 |
|
|
2017
Q3 | $46K | Buy |
3,318
+1,867
| +129% | +$18.6K | ﹤0.01% | 2300 |
|
|
2017
Q2 | $13K | Buy |
1,451
+616
| +74% | +$4.33K | ﹤0.01% | 2539 |
|
|
2017
Q1 | $5K | Buy |
+835
| New | +$4.23K | ﹤0.01% | 2595 |
|
SEI Investments's IMMU Position: Q4 2020 in Review
SEI Investments sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 18,606 shares — an estimated $1.58M sold.
SEI Investments first reported a position in IMMU in Q1 2017 and held it in 15 quarters. The position peaked at $5.43M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- SEI Investments reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- SEI Investments sold 18,606 Immunomedics Inc shares in Q4 2020, an estimated $1.58M.
- SEI Investments first reported a position in Immunomedics Inc in Q1 2017 and held it in 15 quarters.
- SEI Investments's Immunomedics Inc position peaked at $5.43M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on SEI Investments's 13F filing for Q4 2020, filed 8 Feb 2021.